The Democratic Republic of Congo (DRC) announced on Tuesday, August 11, 2026, that confirmed Ebola deaths in the current outbreak have reached 2,011, with 4,381 confirmed cases recorded across five provinces.
Health officials describe this as the fastest‑spreading Ebola outbreak on record, with the death toll jumping from 1,000 to 2,000 in less than a month and half of all deaths occurring in the last 20 days.
By comparison:
- In the 2018–2020 DRC Ebola outbreak, it took more than 12 months to reach 2,000 deaths.
- In the current outbreak, the 2,000‑death mark has been crossed in less than three months since the epidemic was declared on May 15, 2026.
The overall case fatality rate stands at about 45.9%, with over 700 patients still in isolation or hospital care and 869 recoveries reported so far.
Where the outbreak is hitting hardest
The outbreak is concentrated in eastern DRC, a region long affected by armed conflict, population displacement and weak health infrastructure.
Confirmed cases have been reported in five provinces:
- Ituri – the current epicentre, accounting for a large share of cases and deaths.
- North Kivu
- South Kivu
- Haut‑Uele
- Tshopo
Ituri province, in particular, has seen intense transmission, with clinics overwhelmed and health workers struggling to reach remote villages due to insecurity and poor road networks.
The virus strain: Bundibugyo, with no approved vaccine
The current epidemic is caused by the Bundibugyo species of Ebola virus, a rarer strain compared with the more commonly encountered Zaire ebolavirus.
Key implications:
- No approved vaccine currently exists for the Bundibugyo strain, unlike the Zaire strain, for which vaccines such as rVSV‑ZEBOV (Ervebo) are licensed and widely used.
- There is also no specific approved treatment for Bundibugyo Ebola; care is largely supportive (fluids, electrolytes, oxygen, treatment of secondary infections) alongside investigational therapeutics in clinical trials.
This lack of a targeted vaccine and treatment has made containment more difficult, especially in a fast‑moving outbreak in a conflict zone.
Why it’s spreading so fast
Multiple factors are converging to make this the fastest‑growing Ebola outbreak in history:
1. Conflict and insecurity
Eastern DRC has been plagued for decades by rebel insurgencies, militia activity and inter‑communal violence.
- Health teams face access restrictions in areas controlled by armed groups.
- Some communities are displaced repeatedly, making contact tracing and follow‑up extremely difficult.
- Attacks on health facilities and workers, though less frequent than in the 2018–2020 outbreak, still pose a real threat and contribute to fear and mistrust.
2. Weak infrastructure and logistics
- Bad roads, especially during the rainy season, slow down sample transport, patient referrals and delivery of supplies.
- Many affected areas have limited electricity, cold‑chain capacity and laboratory infrastructure, hampering rapid diagnosis and isolation.
3. Community resistance and misinformation
- Rumours, stigma and fear of isolation centres have led some families to hide sick relatives or avoid seeking care until late in the disease course.
- Past experiences with Ebola responses, including heavy security presence and restrictive burial protocols, have sometimes eroded trust in official health messages.
4. Operational challenges: payment disputes and work stoppages
Recent reports highlight payment issues affecting response staff:
- Some health workers and contact tracers have staged work stoppages over delayed or disputed allowances, temporarily disrupting surveillance and follow‑up in certain zones.
- These interruptions reduce the effectiveness of contact tracing, which currently covers only about 67% of identified contacts, leaving many exposed individuals unmonitored.
How this outbreak compares to past ones
Speed of spread
- 2018–2020 DRC Ebola outbreak (Zaire strain):
- Took more than 10 months to reach 2,000 confirmed cases.
- Took over 12 months to reach 2,000 deaths.
- 2026 DRC Ebola outbreak (Bundibugyo strain):
- Reached 2,000 confirmed cases in about two months.
- Surpassed 2,000 deaths in less than three months, with the jump from 1,000 to 2,000 deaths in under a month.
The World Health Organization (WHO) and Africa CDC have repeatedly stated that this is the fastest‑growing Ebola outbreak ever recorded, outpacing even the massive 2014–2016 West Africa epidemic in terms of early growth rate.
Total size
- The 2014–2016 West Africa outbreak remains the largest in absolute terms, with over 28,000 cases and more than 11,000 deaths across Guinea, Liberia and Sierra Leone.
- The current DRC outbreak is now the second‑largest on record in terms of total cases, having surpassed the 2018–2020 DRC outbreak (around 3,481 cases, nearly 2,300 deaths).
As of early August 2026, the DRC has reported over 4,200–4,300 confirmed cases and more than 1,900–2,000 deaths, with the true numbers likely higher due to under‑reporting in insecure areas.
International response and coordination
The outbreak has triggered a major international response, though it has struggled to keep pace with transmission.
Key actors include:
- DRC Ministry of Health and National Institute of Public Health (INSP) – leading case management, surveillance and data reporting.
- World Health Organization (WHO) – coordinating technical support, deploying experts and facilitating access to investigational tools and funding.
- Africa Centres for Disease Control and Prevention (Africa CDC) – supporting regional coordination, laboratory capacity and emergency response.
- UN Ebola coordination mechanisms, including a Senior Ebola Coordinator, who has highlighted the alarming acceleration of deaths on social media.
- Non‑governmental organisations such as Médecins Sans Frontières (MSF), the International Federation of Red Cross and Red Crescent Societies (IFRC) and others, running treatment centres, community engagement and safe burial teams.
Despite these efforts, the response has been outpaced by transmission, particularly in remote or conflict‑affected zones where access is limited and community trust is fragile.
Clinical trials and investigational tools
Given the absence of a licensed Bundibugyo vaccine or treatment, the response has leaned heavily on clinical trials and experimental interventions:
- Therapeutic trials: Several investigational monoclonal antibodies and antivirals are being evaluated in DRC under WHO‑coordinated protocols, though data specific to Bundibugyo remains limited compared with Zaire ebolavirus.
- Vaccine research: Candidate Bundibugyo vaccines are in various stages of development, but none has yet completed the regulatory pathway for emergency use, leaving responders without a ring‑vaccination tool comparable to that used for Zaire Ebola.
Health workers on the ground have called for accelerated research and regulatory flexibility to make promising candidates available under emergency use, while ensuring rigorous safety and efficacy monitoring.
Human cost: “Alarming” and accelerating
Local clinicians describe the situation as dire.
Dr. Jean‑Marie Akandabo, who helps manage patients at a clinic in Ituri, called the 2,000‑death toll “alarming” and urged that response efforts be doubled in affected localities.
UN Senior Ebola Coordinator Julien Harneis underscored the acceleration on social media, noting that half of all deaths occurred in the last 20 days, a stark indicator of how quickly the outbreak is moving.
Behind the numbers are:
- Families losing multiple members in quick succession.
- Health workers operating under extreme pressure, often with insufficient protective equipment, staffing and psychosocial support.
- Communities grappling with fear, stigma and the economic fallout of movement restrictions and reduced trade.
What needs to happen next
Experts and agencies point to several priorities if the outbreak is to be brought under control:
- Scale up rapid response teams in hotspots, especially in Ituri, North Kivu and newly affected zones in Haut‑Uele and Tshopo.
- Improve contact tracing coverage well above the current ~67%, ensuring that most exposed individuals are identified, monitored and supported.
- Resolve payment and logistical issues affecting health workers and contact tracers to prevent further work stoppages and maintain continuity of surveillance.
- Strengthen community engagement, working with local leaders, faith groups and survivors to rebuild trust, counter misinformation and encourage early care‑seeking.
- Accelerate research and regulatory pathways for Bundibugyo‑specific vaccines and treatments, potentially under emergency use frameworks, while maintaining safety and ethical standards.
- Secure funding to sustain the response over the coming months, as the outbreak shows no sign of slowing and may require a prolonged, resource‑intensive effort.
Bottom line
The DRC’s announcement that 2,011 people have died from Ebola in the current outbreak, with 4,381 confirmed cases in less than three months, marks a historic and alarming milestone.
Driven by the Bundibugyo strain, which lacks an approved vaccine or specific treatment, and compounded by conflict, weak infrastructure, community resistance and operational challenges, this has become the fastest‑growing Ebola outbreak ever recorded.
Unless response efforts are rapidly scaled, better funded and more effectively coordinated with communities, the outbreak risks surpassing even the grim totals of the 2018–2020 DRC epidemic and approaching the scale of the West Africa crisis in relative terms, with profound human, social and economic consequences for eastern Congo and the wider region.